Seasoned biopharmaceutical executive with more than 25 years' experience in building strategic patient advocacy functions; translating complex science into relatable stories, and connecting with patient communities across a broad range of therapeutic areas including rare genetic diseases. Demonstrated success partnering with patient communities to incorporate their insights across the drug development spectrum – from discovery, through commercialization, to advancing access. Experienced, empathic leader, contributor and team player who is passionate about changing lives, getting medicines to the people who need them and developing and mentoring high performing teams. Influential speaker and panelist committed to elevating the role of patient advocacy across the life sciences industry. Motivated by relationship development, engagement and implementation strategies that align to corporate goals. Committed to maintaining authentic personal relationships with patients, families and advocates that persist to this day.